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INTRODUCTION 
 
Blunt injury abdomen causes a variety of injuries, the commonest being solid 
organ injury. Among the solid organs, the spleen is most commonly injured. 
Operative management plays a major role in treatment of blunt injury abdomen. 
Various postoperative complications can occur following emergency 
laparotomy including surgical site infection, abdominal abscess, urinary tract 
infection and lower respiratory tract infection. 
Diagnosing these infections becomes particularly challenging following 
splenectomy because of the unusual physiological response to leucocyte count 
and platelet count. 
The aim of this study is to assess the three risk factors i.e Total Leucocyte 
Count, Platelet  count/Total Leucocyte Count Ratio and Injury Severity Score in 
patients undergoing splenectomy and to compare them with other patients 
undergoing laparotomies other than splenectomy for blunt injury abdomen in 
order to achieve a cut off value beyond which persistence of leucocytosis may 
denote infection. 
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AIMS AND OBJECTIVES 
1. To study the WBC Count and Platelet Count(PC)/WBC Count ratio in 
infected and non infected individuals who have undergone post traumatic 
splenectomy compared to other blunt abdomen trauma patients who have 
undergone laparotomy. 
2. To study the relationship of  three prognostic factors : WBC count, 
PC/WBC count ratio and Injury Severity Score in individuals who have 
undergone emergency laparotomy after trauma and their role in post 
operative infection. 
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REVIEW OF LITERATURE 
BLUNT TRAUMA ABDOMEN 
According to WHO by the year 2020, trauma will become the first or second 
leading cause of “loss of productive years of life” for both developed and 
developing countries.[1] Blunt abdominal trauma is the third most common 
form of injury in road traffic accidents and the victims mostly are young, 
productive adults and hence it has got enormous socioeconomic impact.[2] 
Mortality rates are higher in patients with blunt abdominal trauma than in those 
with penetrating wounds, because of the lack of early diagnostic facilities and 
optimal management[3] Blunt injuries are thought to result from a combination 
of crushing, deforming, stretching and shearing forces. The magnitude of these 
forces directly relates to the rate of their acceleration and deceleration as well as 
the relative direction of impact.[4] The spleen and liver are the most commonly 
injured solid organs. Injuries to pancreas, bowel and mesentery, bladder, and 
diaphragm, retroperitoneal structures like kidneys, abdominal aorta, are less 
common. Injuries to the kidney and urinary bladder may be associated with 
pelvic fractures and retroperitoneal haemorrhage.[5] 
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Blunt injury abdomen can be explained by 3 mechanisms: 
 
1. DECELERATION: Rapid deceleration causes differential movement 
among adjacent structures leading to shear forces, causing hollow,solid, 
visceral organs and vascular pedicles to tear at fixed points of attachment. 
2. CRUSHING: Intra abdominal contents are crushed between anterior 
abdominal wall and vertebral coloumn or posterior thoracic cage. Solid 
organs are more vulnerable. 
3. EXTERNAL COMPRESSION:  Direct blows or external compression 
against a fixed object. Causes sudden, dramatic rise in intraabdominal 
pressure and causes rupture of a hollow viscus ( BOYLE’S LAW) 
FAST and CECT Abdomen are very useful in diagnosing extent and 
severity of abdominal injury. 
Non operative management with careful monitoring  may be considered when 
patient is haemodynamically stable, especially in liver injuries due to the firm 
architecture of liver[6]. 
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ALGORITHM FOR EVALUATION AND MANAGEMENT OF BLUNT 
ABDOMINAL TRAUMA 
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SPLEEN 
HISTORICAL BACKGROUND 
Hippocrates in the fourth century bc was one of the first to write on the spleen. 
Hippocrates wrote of a direct connection between the brain and spleen and its 
particular association with the black bile.[7] Aristotle wrote about how the “hot 
nature” of spleen aided digestion.[8] in the early 17th century,  Malphigi thought 
that spleen was associated with anger and was paradoxically also the “seat of 
laughter.”[9] 
The first known splenectomy was performed in 1549 on a 24 yrs old 
female by Adrian Zacarelli for splenomegaly. The first successful partial 
splenectomy was recorded in the year 1590 by Franciscus Rosetti for 
trauma.[10] 
The total splenectomy for trauma was first done by Nicolaus Matthias 
in a patient whose spleen protruded through the flank wound. It was 
performed in Capetown, South Africa in 1678 and partial splenectomy was 
replaced by total splenectomy in trauma cases.[11] Judicious tamponade of the 
organ 
and its first successful suture repair was reported by Ziskoff in Russia in the 
year 1895 for a case of lacerated spleen. 
Role of spleen in immunity has been vastly studied. In 1965 
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Shumacker and Kling elicited that immunity is compromised in children 
whose spleen has been removed in cases of hematological disorders. 
 
EMBRYOLOGY 
Development begins through the formation of the splanchnic mesodermal plate, 
derived from the mesoderm, at embryonic day 12. The embryonic spleen is first 
colonized by erythroid  and myeloid progenitor cells at 2 weeks of gestation. 
The spleen assumes an important hematopoietic role until the fifth month of 
gestation. The organ continues its differentiation and migration to the left upper 
quadrant, where it comes to rest with its smooth, diaphragmatic surface facing 
posterosuperiorly.[12] 
 
 
Fig 1- Development and position of spleen in dorsal mesogastrium 
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ANATOMY 
STRUCTURE AND POSITION 
In a healthy adult, spleen is approximately 12cm long and 7cm wide and weighs 
75 to 100gms.  It is placed deep to 9th, 10th and 11th ribs in the posterior aspect 
of left upper quadrant. Its long  axis is aligned along the 10th rib. It has 2 
surfaces: diaphragmatic and visceral. The visceral surface faces the abdominal 
cavity 
and contains gastric, colic, renal, and pancreatic impressions.  Ligaments of 
spleen are splenocolic ligament, gastrosplenic ligament, phrenosplenic ligament 
and splenorenal ligament. The gastrosplenic ligament contains the short gastric 
vessels; the remaining ligaments are avascular. [13] 
Blood supply: 
The splenic artery which is a branch of the coeliac trunk provides the main 
blood supply. The spleen also receives some of its blood supply from the short 
gastric vessels that branch from the left gastroepiploic artery running within the 
gastrosplenic ligament. 
 
Venous drainage: 
Major venous drainage is through splenic vein which joins superior mesenteric 
vein to form portal vein. 
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Fig 2 – Gross anatomy of spleen 
The splenic parenchyma is composed of two main elements: the red pulp and 
the white pulp . At the interface between the red and white pulp is the narrow 
marginal zone. Blood enters the red pulp through cords comprised of fibroblasts 
and reticular fibers, which contain many macrophages and lack an endothelial 
lining. The blood then passes from these “open” cords to venous sinuses, which 
are surrounded and separated by the same reticulum, and ultimately 
drains into tributaries of the splenic vein. Sinuses of the red pulp are lined 
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by endothelial cells. These cells contain unique stress fibers that connect the 
endothelial cells and that contain actin and myosin–like filaments capable of 
producing a sliding action. When activated, these filaments can create slits or 
gaps between the endothelial cells through which blood can then pass from the 
cords.[14] Aging erythrocytes with stiffer membranes get stuck trying to pass 
into the sinus and are phagocytized by macrophages within the red pulp.[15] 
Around the terminal part of splenic arterioles, a periarticular lymphatic sheath is 
present comprised of T lymphocytes and intermittent aggregations of B 
lymphocytes or lymphoid follicles. When antigenically stimulated, the follicles, 
serving as centers of lymphocyte proliferation, develop germinal centers, which 
regress as the stimulus or infection subsides. 
 
PHYSIOLOGY AND PATHOPHYSIOLOGY 
Spleen has 2 major functions: 
• Cellular 
• Immunological 
 
CELLULAR: Major site of extra medullary  Haematopoiesis, storage, removal 
of  Heinz bodies, Howell-Jolly bodies, and hemosiderin granules, removal of  
aged or abnormal red cells. 
Spleen is the most important site of selective erythrocyte sequestration. 
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There is an accountable relation between the platelets and splenic 
cells. Normally, about one third of the platelet mass is pooled in the spleen, 
and this pool exchanges freely with the circulating platelets that have a life 
span of about 10 days. This is the main reason for thrombocytosis in a post 
splenectomy patient. 
IMMUNOLOGICAL: Both innate and adaptive immune responses 
occur within the spleen. It plays a major role in Generation of lymphocytes, 
production of propredin, opsonin, tuftsin, interferon and antibody synthesis 
(IgM). 
This is the reason for the risk posed by pneumococcus and Haemophilus 
influenzae to an asplenic patient.[16-18] 
 
 
 
Indications for splenectomy 
Trauma 
• Accidental 
•  Operative 
Oncological 
• Part of en bloc resection 
•  Diagnostic 
•  Therapeutic 
15 
 
Haematological 
• Spherocytosis 
•  Purpura (ITP) 
•  Hypersplenism 
• Portal hypertension 
• Variceal surgery 
 
SPLENIC INJURY  
The spleen is the most commonly injured abdominal organ in trauma with 
23.8% of abdominal trauma patients demonstrating  splenic injuries. Many 
splenic 
injuries are self-limited, demonstrating no evidence of ongoing bleeding; others 
require splenectomy, which in most cases is straightforward. Despite this, the 
mortality after blunt splenic injury is 9.3%. Direct compression of 
the spleen with parenchymal fracture is the most common pathophysiologic 
mechanism followed by rapid deceleration.Spleen is the most commonly 
bleeding intra-abdominal organ, as noted in unstable patients with intra-
abdominal fluid on focused assessment with sonography in trauma (FAST). 
Splenic injuries are identified during laparotomy in unstable patients taken to 
operating room emergently. In stable patients, the mainstay of diagnosing 
splenic injuries is by abdominal CT with IV contrast. 
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Splenic injuries may appear as disruptions in the normal splenic parenchyma, 
with surrounding hematoma and free intra-abdominal blood. On occasion, 
active bleeding can be identified by visualizing extravasation of contrast 
material that appears as a highdensity blush or accumulation of contrast-laden 
blood. 
Splenic injuries may also present as subcapsular haematomas, pseudoaneurysm 
or complete devascularisation at the hilum. 
Penetrating splenic trauma is less common but is still present in 8.5% of all 
penetrating abdominal injuries in the National Trauma Data Bank. 
Splenic injuries are graded by the American Association for the Surgery of 
Trauma organ injury scaling system, which relies on the parenchymal or 
subcapsular characteristics and the vascular involvement. 
Splenic injury patients who are haemodynamically stable may be managed by 
conservative management or by angiography and selective embolisation. 
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AAST SPLEEN INJURY SCALE 
INJURY 
GRADE 
INJURY 
TYPE 
DESCRIPTION OF INJURY 
I Hematoma Subcapsular, <10% surface area 
 Laceration Capsular tear, <1 cm parenchymal depth 
II Hematoma Subcapsular, 10% to 50% surface area; 
intraparenchymal, <5 cm in diameter 
 Laceration Capsular tear, 1 to 3 cm parenchymal depth 
that does not involve a trabecular vessel 
III Hematoma Subcapsular, >50% surface area or 
expanding; ruptured subcapsular or 
parenchymal hematoma; intraparenchymal 
hematoma ≥5 cm or expanding 
 Laceration >3 cm parenchymal depth or involving 
trabecular vessels 
IV Laceration Laceration involving segmental or hilar 
vessels producing major devascularization 
(>25% of spleen 
V Hematoma Completely shattered spleen 
 Laceration Hilar vascular injury devascularizes spleen 
Table 1 : AAST grading of splenic injuries. 
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Fig 3 : Grade I: sub-capsular fluid involving < 10% of the splenic surface.
 
Fig 4- Grade I: sub-capsular fluid involving < 10% of the splenicsurface. 
Capsular tear < 1cm depth. 
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Fig 5- Grade II: sub-capsular hematoma, 10% to 50% surface area; 
intra-parenchymal hematoma, < 5 cm in diameter. 
 
Fig 6- Grade II: capsular tear, 1 to 3 cm parenchymal depth that does 
not involve a trabecular vessel. 
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Fig 7- Grade III: sub-capsular hematoma, laceration and subcapsular 
contrast extravasation. 
 
 
Fig 8- Grade III: laceration of more than 3 cm in depth radiating 
from the splenic hilum. 
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Fig 9- Grade IV: laceration involving segmental or hilar vessels 
producing major devascularization (>25% of spleen). 
 
Fig 10- Grade V: shattered spleen and hilar vascular injury. 
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Fig 11- Splenic injury with sub-capsular hematoma. Despite only a 1-cm 
capsular tear, this injury demonstrated ongoing hemorrhage. 
Non operative management of splenic injuries is strictly restricted to 
haemodynamically stable patients with no physiologic indication of ongoing 
blood loss. Physiologic stability includes , lack of tachycardia,  a normal blood 
pressure, no physical examination findings indicating shock, and absence of 
metabolic acidosis. It is more labour intensive than operative management due 
to the need for intensive monitoring of the patient. Until intravascular 
equilibrium occurs, the haemoglobin levels cannot reflect the blood loss. 
Candidates with mild hemodynamic instability, but responding to crystalloid 
infusion can be considered for non-operative management. Non-operative 
management is reserved for grade I, II injuries and isolated grade III injuries. 
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Angiography and selective embolization represent the recent advance in 
management of splenic injury. One major benefit of angiography is the potential 
to obstruct sites of bleeding endovascularly by angioembolization. Stable 
patients who are found to have a pseudoaneurysm on CT may benefit from 
angioembolization to eliminate blood flow through the injured segment of 
spleen. 
Haemodynamic instability at presentation or failure of conservative 
management is the indication for operative management. 
 
OPERATIVE PROCEDURE : OPEN SPLENECTOMY 
A Midline laparotomy incision is made with packing of all four quadrants in an 
unstable patient. A retractor is used to expose left upper quadrant. The 
beginning of splenectomy is marked by retracting the spleen posteromedially to 
visualize retroperitoneal attachments  and dividing the peritoneum laterally. 
Division begins at the white line of Toldt and continued superiorly till short 
gastric vessels are exposed. After dividing the peritoneum, a blunt plane is 
created posterior to the spleen in a medial direction, extending behind the tail of 
the pancreas, mobilizing the entire spleen and distal pancreas, allowing the 
spleen to be delivered up into the wound. Short gatric vessels are ligated and 
divided taking great care to avoid greater curvature of stomach. Hilar vessels are 
then clamped and ligated and splenectomy done taking great care to avoid 
24 
 
injuring tail of pancreas. Drain is kept only when injury to tail of pancreas is 
suspected. Postsplenectomy 
vaccines must be provided to ensure protection from encapsulated 
bacteria, including Streptococcus pneumoniae, Neisseria meningitidis, 
and Haemophilus influenzae. 
Since patients who usually benefit from splenic salvage techniques are managed 
nonoperatively, these techniques are less commonly used now. 
 
FIG 12: Splenocolic ligament divided at the beginning of splenectomy 
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.  
Fig 13: Interrupted pledgeted sutures may effectively control hemorrhage from 
the cut edge of the spleen. 
 
POST SPLENECTOMY COMPLICATIONS 
• Haemorrhage: Slippage of ligature 
• Left basal atelectasis and pleural effusion. 
• Injury to stomach: 1. Gastric mucosal damage causing haematemesis  
                                        2.Injury to greater curvature causing fistula 
• Injury to tail of pancreas causing pancreatitis, abscess,fistula 
• Thrombocytosis leading to Deep vein thrombosis and pulmonary 
embolism. 
• Overwhelming Post Splenectomy Infection  : Capsulated organisms like 
Streptococcus pneumoniae, Neisseria meningitides, Haemophilus 
influenzae and Escherichia coli. 
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POST SPLENECTOMY LEUCOCYTOSIS 
Mounting of an efficient immune response requires fast mobilization and 
distribution of lymphocytes. The kinetic aspects of lymphocyte trafficking is 
responsible for postsplenectomy leukocytosis. Lymphocytes cross from blood 
across a specialized endothelium of post capillary venule into lymph node and 
exit via efferent lymphatica and thoracic duct..[19,20] Most lymphocytes circulate 
through spleen because direct access to marginal zone bypasses the specialized 
endothelium.  
The total lymphocyte pool in is estimated to be approximately 50*1010 
cells  of which 15*1010 circulate through lymphoid tissues.[21]. At any given time 
only 1*1010 lymphocytes circulate in the blood with a short transit time of    20-
36minutes for exchangeable cells resulting in high turnover of migratory 
lymphocytes about 50 times per day[22,23] and total daily exchange of 50* 1010  
between blood and tissues. The spleen has highest lymphocyte uptake of about 
40% during the early stages of recirculation. [24] During intermediate and late 
stages of recirculation, lymphocytes are predominantly found in lymph nodes. 
The transit time of migrating lymphocytes through the spleen is significantly 
shorter than through lymph nodes and a higher number of lymphocytes pass 
through the spleen than through the thoracic duct. 
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Hence splenectomy results in a slower overall clearance of lymphocytes from 
peripheral blood. Moreover neutrophils are destroyed in spleen. Hence, 
splenectomy may result in neutrophilia. As a result of slower clearance of 
lymphocytes and reduced destruction of neutrophils, there is physiological 
leukocytosis post-splenectomy . 
 
POST SPLENECTOMY THROMBOCYTOSIS 
Spleen is the major site where destruction of platelets takes place. Hence, there 
is physiological thrombocytosis following splenectomy. 
 
LIVER INJURY 
Within the National Trauma Data Bank, liver injuries occurred in 3.0% of all 
patients, whereas 22.2% of patients with blunt mechanisms sustained 
hepatic trauma, making it the second most common organ to be injured in 
trauma. 
Mechanisms of blunt hepatic trauma include compression with direct 
parenchymal damage and shearing forces, which tear hepatic tissue and disrupt 
vascular and ligamentous attachments. 
Liver injuries are mostly first diagnosed on entering the abdomen in the 
unstable patient explored for free fluid on FAST examination. 
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Those who do not require immediate operation should be imaged with 
abdominal 
Contrast enhanced CT, which is capable of providing excellent anatomic detail 
that allows highly accurate characterization of injuries. Common findings on 
CT indicative of liver injury include disruption of the hepatic parenchyma with 
perihepatic blood or hematoma and hemoperitoneum. 
Bleeding from the liver can be seen on CT as extravasation of contrast material 
either within the liver parenchyma or into the peritoneal space. 
Depending on CT findings, liver injuries are classified according to AAST 
classification. 
 
Fig 14: Grade IV liver laceration involving the right hepatic lobe on abdominal 
CT. Note the focus of active extravasation of contrast material within the 
injured liver parenchyma at the periphery of the injury as identified by the 
arrow. 
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AAST LIVER INJURY SCALE 
INJURY 
GRADE 
INJURY 
TYPE 
DESCRIPTION OF INJURY 
I Hematoma Subcapsular, <10% surface area 
 
Laceration Capsular tear, <1 cm parenchymal depth 
II Hematoma Subcapsular, 10% to 50% surface area; 
intraparenchymal, <10 cm in diameter 
 
Laceration Capsular tear, 1 to 3 cm parenchymal depth, 
<10 cm in length 
III Hematoma Subcapsular, >50% surface area of ruptured 
subcapsular or parenchymal hematoma; 
intraparenchymal hematoma >10 cm or 
expanding 
 
Laceration >3 cm parenchymal depth 
IV Laceration Parenchymal disruption involving 25% to 75% 
hepatic lobe or 1 to 3 Couinaud segments 
V Laceration Parenchymal disruption involving >75% of 
hepatic lobe or >3 Couinaud segments 
within a single lobe 
 
Vascular Juxtahepatic venous injuries (i.e., retrohepatic 
vena cava/central major hepatic veins) 
VI Vascular Hepatic avulsion 
 
 
 
 
30 
 
OPERATIVE MANAGEMENT OF LIVER TRAUMA 
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 ABBREVIATED INJURY SCALE[24]  
Created by the Association for Advancement of Automotive Medicine. 
The score describes three aspects of injury 
• Type  
• Location 
• Severity 
It is denoted by seven numbers ranging from 1-7. 
1. Body region 
2. Type of anatomical structure 
3,4. Specific anatomical structure 
5,6. Level  
7. Severity of score 
Severity of score is classified as: 
AIS 1 : Minor 
AIS 2 : Moderate 
AIS 3 : Serious 
AIS 4 : Severe 
AIS 5 : Critical 
AIS 6 : Maximal(Currently untreatable) 
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INJURY SEVERITY SCORE (ISS) & NEW INJURY 
SEVERITY SCORE (NISS) 
It is based on AIS and correlates with mortality, morbidity and other measures 
of severity. 
It is calculated as the sum of the squares of the highest AIS scores in each of the 
three most injured body regions; 
• Head or neck 
• Face 
• Chest 
• Abdominal or pelvic contents. 
• Extremities or pelvic girdle. 
• External 
Score ranges from 1-75. If an injury is assigned an AIS score of 6, the  
ISS score is automatically assigned as 75. 
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ISS 
SCORE SEVERITY 
1-8 MINOR 
9-15 MODERATE 
16-24 SERIOUS 
25-49 SEVERE 
50-74 CRITICAL 
75 MAXIMUM 
 
Since multiple injuries within the same body region are given a single score, a 
modification of the ISS, the "New Injury Severity Score" (NISS), has been 
given shape.  
Three most severely injures organs are assigned a score and their sum of squares 
will yield the New Injury Severity Score. 
 
POST OPERATIVE INFECTIONS 
Postoperative infection includes any infection that affects a post operative 
patient and not just those that require an surgical intervention as thought earlier. 
The most common infections are: 
• Surgical site infections 
• Hospital or ventilator acquired pneumonia 
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• Aspiration pneumonitis post endotracheal intubation 
• Urinary tract infection 
• Central line associated blood stream infections 
Surgery’s inherent invasiveness creates portals of entry for pathogens to invade 
the host through natural epithelial barriers.   
Surgical illness is immunosuppressive (e.g., trauma, burns, malignant tumors), 
similar to therapeutic immunosuppression after solid organ transplantation. 
Postoperative infections are easier to prevent than to treat and it is prudent for 
every physician who is in contact with his patient, to take strict aseptic 
precautions. 
Universal hand washing techniques should be practiced. 
Wound dressing must be done under strict aseptic precautions. Drains and 
catheters should be avoided as much as possible. If unavoidable, must be 
removed as early as possible. Judicious use of prophylactic and therapeutic 
antibiotics is necessary to maintain the balance between preventing infection 
and  multidrug resistance. 
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RISK FACTORS :  
HOST FACTORS: 
The host is defined by genotype, expressed phenotypically as characteristic 
traits. Innate immunity provides continuous surveillance against tissue invasion 
by foreign antigens in the interstitial spaces just beneath epithelial barriers. 
Innate immunity is responsible for providing epithelial barrier 
preventing the invasion of foreign antigens. Even though commensals are 
present throughout the body, infection occurs only when there is a portal of 
entry through a breech in epithelial barrier like surgery or intravenous catheter 
insertion. Surgical stress produces cortisol which further reduces immunity. 
Injury also stimulates a repair response (inflammation), which may cause a 
wide-ranging autodestructive augmentation of  the inflammatory response. 
Older age ( age ≥65 years) is a definite risk factor for adverse outcomes from 
infection, related to immune senescence and an increased incidence of 
nosocomial infection. Even transient Hyperglycemia induces immune cell 
dysfunction and is a major risk factor for infection. 
Overview of the Stress 
STRESS RESPONSE TO INJURY 
Activation of the autonomic nervous system 
Peripheral insulin resistance 
Activation of hypophyseal-pituitary-adrenal axis 
Production of reactive oxygen and nitrogen intermediates 
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Production of proinflammatory and anti-inflammatory cytokines and lipid 
mediators 
Acute-phase changes of hepatic protein synthesis 
Recruitment and activation of neutrophils, monocytes-macrophages, and 
lymphocytes 
Upregulation of procoagulant activity 
 
Factors causing increased risk of post operative infections 
 
• Extremes of age (neonates, very old adults) 
• Malnutrition 
• Obesity 
• Diabetes mellitus 
• Prior site irradiation 
• Hypothermia 
• Hypoxemia 
• Coexisting infection remote to surgical site 
• Corticosteroid therapy 
• Recent operation, especially of chest or abdomen 
• Chronic inflammation 
• Hypocholesterolemia 
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Genetics and Genomics of Trauma and Sepsis 
No studies have so far shown a sex predeliction for infection and sepsis.[25,26] 
Genomic variability may correlate  with disease susceptibility in infections. 
Nucleotide structures of genes containing single nucleotide polymorphisms 
(SNPs) and single point mutations related to inflammation like tumor necrosis 
factor-α [TNF-α], interleukin [IL]-1, IL-6, and IL-8), the anti-inflammatory 
factors (e.g., IL-10, IL-1 receptor antagonist), the innate immune receptor (e.g., 
Toll-like receptor 4), and the coagulation system (e.g., factor V, plasminogen 
activator inhibitor-1) have been associated with a predisposition to sepsis.[27] 
Due to heterogenicity of  infection and the response mounted against it, it is 
difficult to  pinpoint a single nucleotide pleomorphism to characterize increased 
risk of infection in an individual. 
 
INTERACTION BETWEEN HOST AND THERAPY 
Risk of infection is increased by the following factors: 
• Injury itself. 
• Impairment of host defences 
• Resuscitation 
• Definitive care 
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Hypothermia 
Hypothermia may occur due to evaporative loss in a large exposed wound or 
intracavitary surgery, resuscitation with unwarmed iv fluids and blood products 
and exposure. Hypothermia leads to vasoconstriction and decreased 
microcirculation, which is aggravated by hypovolemia, inflammatory response, 
coagulation pathway decreased transfused red cell deformability[28,29] 
This affects cardiovascular performance and decreases immunity leading to post 
operative morbidity and mortality. 
Tissue hypoxia 
Tissue hypoxia predisposes to Surgical site infection. 
It occurs due to massive trauma to face, chest,airway or lung, massive blood 
loss, Acute Respiratory Distress Syndrome and caediovascular instability.[30] 
Supplemental oxygen decreases risk of surgical site infection.[31] 
RESUSCITATION 
Injudicious resuscitation can have as many adverse outcomes than insufficient 
resuscitation. The amount and nature of fluid to be administered has to be 
calculated meticulously. Earlier crystalloids were preferred over colloids due to 
cost effectiveness and almost equal effectiveness[32].. Now resuscitation with 
colloids show less mortality.[33] Resuscitation of immune system is the most 
important factor, failure of which can lead to increased mortality.[34] 
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BLOOD TRANSFUSION 
Though blood transfusion is life saving in trauma, it is associated with increased 
exponential risk of infection even after a single transfusion and becoming near 
certainity after 15 units of transfused blood products.[35,36] Altered leukocyte 
antigen presentation and a shift to the T helper 2 cell phenotype causes 
immuno-suppression following blood transfusion. 
Risk of infection following blood transfusion is increased 3 times in surgical 
patients and 5 times in trauma patients. Critically ill and ventilator dependant 
patients are also at a higher risk of infection following blood transfusion.[37] 
Prolonged storage of banked blood causes  loss of high energy 
membrane phosphates which leads to impaired red cell 
deformability, disruption of microcirculation, and impaired oxygen delivery[38]. 
 As a result blood transfusion does not increase oxygen consumption [39] 
but instead increase organ dysfunction [40]. So it is better to be conservative 
while deciding on blood transfusion to stable patients in intensive care unit[41] 
BLOOD SUGAR CONTROL 
Hyperglycemia reflects catabolism and insulin resistance assosciated with 
surgical stress  and also impairs host immune defence. Inadequate glycemic 
control during the peri operative period increases the risk of infection and 
worsens the outcome 
from sepsis in both diabetic and non diabetics. Blood glucose  more than 200 
mg/dl is associated with four times increased risk of surgical site infection. 
40 
 
Blood glucose level below 110 mg/dL is associated with a 40% decrease in 
mortality among critically ill postoperative patients  and also fewer nosocomial 
infections and less organ dysfunction. [42] 
Effects of Hyperglycemia on Immune Cell Function 
• Decreased respiratory burst of alveolar macrophages 
• Decreased insulin-stimulated chemokinesis 
• Glucose-induced protein kinase C activation 
• Increased adherence 
• Increased adhesion molecule generation 
• Spontaneous activation of neutrophils 
 
Effects of Stress Response on Carbohydrate Metabolism 
• Enhanced peripheral glucose uptake 
• Hyperlactatemia 
• Increased gluconeogenesis 
• Depressed glycogenolysis 
• Peripheral insulin resistance 
 
In order to reduce  risk of hypoglycemia following insulin therapy, the 
maintenance blood glucose level has been increased from 110 mg/dl to 140- 
180 mg/dl[43]. 
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NUTRITION 
Nutrition plays a vital role in preventing post operative morbidity and mortality. 
In order to convert the catabolic state of surgical stress back to anabolism, 
excess calories of 25-30kcal/day and 1g nitrogen/kg/day is required in excess of 
basal requirements. It is challenging to provide adequate calories and protein 
while simultaneously avoiding hyperglycemia. Parenteral nutrition may offer  
no advantage over not feeding the patient at all due to catheter related infection 
and hyperglycemia. Early enteral nutrition within 48 hrs is preffered and id 
found to reduce infections.[44,45]. 
CONTROL OF INFECTION 
General principles of surgical care, critical care, and infection 
control must be adhered to at all times. 
 Resuscitation must be precise and rapid; Both overresuscitation and 
underresuscitation increase the risk of infection. It is also necessary to 
immediately identify the underlying pathology and take measures to treat it. 
Central venous catheters placed under sub optimal conditions, urinary catheters 
and drains are all sources of infection and must be identified and rectified 
immediately. Infection control is an individual and collective responsibility. 
Hand hygiene is the most effective means to reduce the spread of infection, but 
compliance is a continual challenge.[46] Alcohol gel 
hand cleansers are effective,[47] except against the spores of Clostridium 
difficile, which requires cleansing with soap and water.[48] 
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Universal precautions—cap, mask, gown, gloves, and protective eyewear—
must be observed whenever there is a risk of splashing of body fluids. 
Endogenous flora are the most common source of infection. Skin surfaces, 
artificial airways, gut lumen, wounds, catheters, and 
inanimate surfaces (e.g., bed rails, computer terminals)[49] may 
become colonized. Any break in natural epithelial barriers (e.g., 
incisions, percutaneous catheters, airway or urinary catheters) 
creates a portal of entry for invasion of pathogens. The fecal-oral 
route is the most common manner whereby pathogens reach the 
portal, but health care workers facilitate the transmission of 
pathogens on their hands. Contact isolation is an important part of infection 
control and should be used selectively to prevent the spread of pathogens such 
as methicillin-resistant Staphylococcus aureus (MRSA), vancomycinresistant 
enterococci (VRE), or MDR gram-negative bacilli. 
However, contact isolation may decrease the amount of direct 
patient contact.[50] An appropriate balance must be struck because 
reduced nurse staffing of ICUs has been independently associated 
with an increased risk of a number of nosocomial infections.[51] 
 
CATHETER CARE: 
Optimal catheter care includes: 
• Insertion only when necessary. 
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• Appropriate skin preparation and barrier protection 
• Appropriate catheter selection (antiseptic or antimicrobial coated) 
• Proper dressing of indwelling catheters 
• Removal as soon as no longer needed, or as is practicable, but no longer 
than 24 hours after insertion under less than ideal circumstances 
(e.g.,trauma bay, cardiac resuscitation). 
High risk catheters are nontunneled central venous catheters and pulmonary 
artery catheters pose the highest risk for infection. Other catheters associated 
with increased risk of infection includes endotracheal tubes, intercostal 
thoracostomy 
catheters, ventriculostomy catheters for intracranial pressure monitoring and 
urinary bladder catheters.  
Risk of pneumonia increases by 1% to 3% for every day of mechanical 
ventilation and endotracheal intubation [51] . 
Most common skin antiseptic that is used is chlorhexidine gluconate, 
a phenolic biguanide derivative, in concentrations of 0.5% to 4% alone or in 
lower concentrations in combination with an alcohol. This antiseptic has 
cidal activity i.e., bactericidal, viricidal and fungicidal which is slow but 
persistent. Chlorhexidine has been most commonly used for vascular 
catheter insertion and it has been found to be superior to povidone iodine 
solution. It is also being recommended for surgical site preparation, topical 
bathing of critically ill patients and as an antiseptic coating for indwelling 
44 
 
catheters. For microbicidal effect of povidone iodine solution, one must 
apply the solution and allow it to dry. Unless a mucous membrane has to be 
prepared its use has been discouraged [52, 53, 54, 55, 56] 
It is mandatory to have full barrier precautions during bedside 
catheterization procedures except for arterial and urinary bladder 
catheterization for which sterile gloves and field is more than enough if 
maintained meticulously. 
If a central venous catheter is inserted under suboptimal conditions, 
then ensure that the catheter is changed to a different site as soon as patients’ 
hemodynamic condition improves, but not more than 24 hours of insertion. 
A stat dose of first generation cephalosporin does prevent infections 
following tube thoracostomy or ventriculostomy, but is not indicated for 
vascular or bladder catheterization. 
It is necessary to maintain dressings carefully which becomes 
challenging in cases of agitated patients and irregular body surface. 
Mentioning the date and time of dressing change over the dressing itself is 
simple and effective. 
One should not shift dressing cart from patient to patient, instead 
sufficient dressing materials should be kept in the patient’s room. Inanimate 
fomites such as scissors can transmit pathogens from one patient to another. 
Hence it is prudent to implement care bundles and catheter care teams to reduce 
the risk of catheter line associated bloodstream in
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tract infections [57, 58]. 
Catheter choice also plays an important role in reducing the risk of infection 
related to endotracheal tubes, central venous catheters and urinary catheters. 
Those areas that cannot be reached by routine endotracheal suctioning such as 
the sub-glottic region may be cleared by continuous aspiration of sub-glottic 
secretions through an endotracheal tube provided with an extra lumen which 
opens to the airway just above the balloon. 
Continuos aspiration of subglottic secretions decrease the incidence of 
ventilator associated pneumonia by 50%. Endotracheal tubes impregnated with 
silver are highly effective in reducing the risk of ventilator associated 
pneumonia and mortality. Catheter related infections in high prevalence units 
can be reduced by antibiotic coated or antiseptic coated tubes. Silver coated 
urinary catheters are associated with decreased incidence of catheter related 
bacterial cystitis [59, 60]. 
SPECIFIC INFECTIONS 
 
SURGICAL SITE INFECTIONS: 
Surgical procedures are classified into 
Clean procedures - affect only skin structures and other soft tissues. 
Clean contaminated procedures- open a hollow viscus under controlled 
circumstances (e.g., elective aerodigestive or genitourinary tract surgery) 
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Contaminated procedures- introduce a large inoculum of bacteria into a 
normally 
sterile body cavity, but too briefly for infection to become established 
during surgery (e.g., penetrating abdominal trauma, enterotomy 
during adhesiolysis for mechanical bowel obstruction). 
Dirty procedures - performed to control established infection 
(e.g., colon resection for perforated diverticulitis) 
RISK FACTORS FOR DEVELOPING SURGICAL SITE INFECTIONS 
Patient Factors 
Ascites (for abdominal surgery) 
Chronic inflammation 
Corticosteroid therapy  
Obesity 
Diabetes 
Extremes of age 
Hypocholesterolemia 
Hypoxemia 
Peripheral vascular disease (for lower extremity surgery) 
Postoperative anemia 
Prior site irradiation 
Recent operation 
Remote infection 
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Skin or nasal carriage of staphylococci 
Skin disease in the area of infection (e.g., psoriasis) 
Undernutrition 
Environmental Factors 
Contaminated medications 
Inadequate disinfection or sterilization 
Inadequate skin antisepsis 
Inadequate ventilation 
Treatment Factors 
Drains 
Emergency procedure 
Hypothermia 
Inadequate antibiotic prophylaxis 
Oxygenation (controversial) 
Prolonged preoperative hospitalization 
Prolonged operative time 
Factors determining microbiology of surgical site infections include 
the nature of the procedure, whether a body cavity or a hollow viscus is 
entered during surgery and location of the incision. Most surgical site 
infections are the result of microorganisms that enter through the surgical 
incision wound. Hence the most common organism responsible for surgical 
site infection includes all the gram positive organisms - Staphylococcus 
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epidermidis, Staphylococcus aureus, and Enterococcus species. For those 
surgeries that are done through infrainguinal incision and 
intracavitatory surgery, gram negative organisms such as Escherichia coli 
and Klebsiella spp are the most common pathogens. Anaerobic organisms 
are the potential pathogens in pharynx, female genitourinary and lower 
gastrointestinal surgeries. Hence antibiotic prophylaxis must be directed 
appropriately against these antigens. Statistics indicate that the incidence of 
surgical site infections vary from less than 5% for clean surgeries to about 
20% for dirty procedures. 
The factors included under National Nosocomial Infections 
Surveillance System (NNIS) and its successor program, the National 
Healthcare Safety Network (NHSN) is 
1. Wound classification 
2. ASA class 3 or higher 
3. Prolonged operative time, where time is longer than the 75th percentile 
for the given procedure [61, 62, 63]. 
According to NNIS-NHSN risk of surgical site infection increases 
with increase in the number of risk factors irrespective of the type of surgery 
performed. Laparoscopic surgeries are associated with decreased incidence 
of surgical site infection. Factors responsible for decreased incidence of 
surgical site infection includes decreased wound size, limited use of cautery 
in the abdominal wall and a diminished stress response to tissue injury. 
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Hypothermia is another important risk factor for surgical site infection 
which occurs because of water loss due to evaporation, administration of 
normothermic fluids and other factors [64].  
Controversies exist whether peri-operative oxygen administration is a boon 
for infection prevention [65]. The ischemic milieu of fresh surgical incision is 
vulnerable to bacterial invasion. Moreover administration of oxygen is found 
to have a beneficial antibacterial effect. Though there are no convincing 
studies to suggest the usefulness of oxygen in preventing surgical site 
infections, but there exists one meta-analysis suggesting the advantage of 
oxygen in reducing the risk of infection. 
It has been found that drains instead of preventing infections, is seen 
to increase the risk of infection. Drains prevent wound epithelialisation and 
become a conduit, creating a portal of entry for the pathogens that has been 
colonising the skin. Several studies conducted on placing the drains in clean 
or clean contaminated procedures has shown that they increase the chances 
of infection rather than decreasing the risk [66, 67]. 
Surgical Infection Prevention Project was incorporated into Surgical 
Care Improvement Project with additional recommendations which includes 
the following 
• Antibiotic Prophylaxis 
• Glucose Control 
• Hair Removal 
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• Hypothermia 
 
POST OPERATIVE PNEUMONIA 
Post-operative patients especially patients requiring ventilators are 
susceptible to pneumonia. Ventilator associated pneumonia (VAP) is defined 
As pneumonia presenting 48-72 hours after intubation. 
Early onset. 
Occurring within 5 days of intubation. 
Commonly seen in trauma patients mainly due to aspiration of gastric contents. 
Causative organisms include MRSA, Streptococcus pneumoniae and 
Haemophilus influenzae. 
 
Late onset ventilator associated pneumonia  
Defined as that occurring on or after 5 days after intubation. Most common 
organisms involved in causing late onset pneumonia are the multidrug resistant 
pathogens. For e.g. Acinetobacter, Pseudomonas aeruginosa, MRSA. 
 
Risk factors associated with ventilator associated pneumonia : 
• Age ≥60 yr 
• Acute respiratory distress syndrome 
• Chronic obstructive pulmonary disease or other underlying pulmonary 
• disease 
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• Coma or impaired consciousness 
• Serum albumin level <2.2 g/dL 
• Burns, trauma 
• Blood transfusion 
• Organ failure 
• Supine position 
• Large-volume gastric aspiration 
 
• Sinusitis 
• Immunosuppression 
• Prolonged mechanical ventilation\ 
Non-invasive intermittent positive pressure ventilation should be 
used whenever possible in place of mechanical ventilation. Orotracheal 
intubation is preferred over nasotracheal intubation because of increased risk of 
sinusitis in the latter. 
Attempts must be made to assess daily the readiness to extubate 
the patient, to adopt standard weaning protocols and increase ICU 
manpower. 
Various methods to reduce the risk of aspiration pneumonitis includes:[68, 69, 
70]  
• Maintenance of cuff pressure around 20 cm H2O 
• Using newer cuff materials which helps to establish tight seal 
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• Continuous aspiration of subglottic secretions. 
• Semirecumbent position 
• Post pyloric feeding 
• Promotility agents such as erythromycin 
Shorr AF, Duh MS, Kelly KM, et al found that enteral nutrition started within 
48 hours of intubation is associated with increased chances of aspiration 
pneumonitis. 
Shorr AF, Duh MS, Kelly KM, et al also found that blood transfusion 
is also associated with increased risk of pneumonia. 
Clinical Pulmonary Infection Score (CPIS) [71] incorporates the 
Following: 
Temperature 
Leukocyte count 
Chest x-ray infiltrates 
Appearance and volume of tracheal secretions 
PaO2, FIO2 
Culture and Gram stain of tracheal aspirate 
Each factor is awarded 0-2 points each to yield a maximum of 12 
points. A score >6 is associated with increased chances of developing 
pneumonia. However the specificity of this score is increased when cultures 
are taken into account. 
Organisms responsible for causing ventilator associated pneumonia 
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include Pseudomonas aeruginosa, Enterobacteriaceae, Streptococcus 
pneumoniae, Staphylococcus aureus, and Haemophilus influenzae. 
Streptococci viridans, Enterococci species, Candida species and 
Coagulasenegative 
staphylococci can also cause respiratory dysfunction 
Urinary Tract Infection 
Catheter-associated bacteriuria or candiduria typically presents as a 
colonization picture. It is mostly asymptomatic, and is not a likely cause of 
fever or secondary bloodstream infection [72, 73], even in 
immunocompromised patients [74]*83*, unless there is urinary tract obstruction, 
history of recent urologic manipulation, injury, or surgery, or neutropenia. 
As effective prevention tactics, emphasis is now being placed on avoidance or 
brief duration of catheterization (e.g., <48 hours for elective surgery patients) 
[75’76]
 and on the use of silver alloy–coated catheters[77,78]  when and where 
instrumentation is deemed appropriate. The typical signs and symptoms (e.g., 
dysuria, urgency, pelvic or flank pain, fever or chills) that correlate with 
bacteriuria in noncatheterized patients are rarely reported in ICU patients with 
documented catheterassociated bacteriuria or candiduria (>105 CFU/mL)[79,80] . 
In the intensive care unit, most urinary tract infections are related to urinary 
catheters and are caused by multiresistant, nosocomial, gram-negative bacilli 
other than E. coli, Enterococcus species and yeasts [81]. 
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Confirmation is by collecting a urine specimen which should be examined by 
direct microscopy, Gram stain and quantitative culture [82] 
The specimen should be aspirated from the catheter sampling port after 
disinfecting the port with 70% to 90% alcohol, and should not be collected from 
the drainage bag. 
Contrary to community-acquired urinary tract infections, pyuria may be absent 
with catheter-associated urinary tract infection. Even if present, pyuria is not a 
reliable predictor of UTI in the presence of a catheter [83]. The concentration 
of urinary bacteria or yeast required to cause any symptomatic urinary tract 
infection or fever is unclear, though it is clearly predictive that counts higher 
than 103 CFU/mL represent true bacteriuria or candiduria in catheterized 
patients [84 ] 
 
Intra-Abdominal Infection 
Intra abdominal infections are dichotomized into uncomplicated (uIAI) and 
complicated (cIAI) [85] and, more recently, as to whether they arose in the 
community associated (CAIAI) or hospital-associated (HA-IAI) setting (e.g., 
associated with a colon anastamotic dehiscence), and whether they are low, 
moderate, or high risk for clinical failure, morbidity, or death.  
In uIAIs, the infection is restricted to a single organ and there may be no 
perforation of the gastrointestinal (GI) tract. Uncomplicated IAIs is never 
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associated with serious illness but a complicating hospital acquired infection 
may worsen the matter [86]. 
cIAIs will extend beyond the involved organ and further into the 
peritoneal cavity through the perforated viscus, thereby resulting in a greater 
SIRS response. The severity of infection depends on the extent to which it is 
contained by local intra-peritoneal defenses. In cases of high-risk or hospital 
acquired cIAI, broad-spectrum empirical antimicrobial therapy is indicated 
because of an increased risk of causative MDR pathogens [87,88] 
There is a mortality rate of 25-35% in patients with abdominal sepsis [89, 90], but 
may reach upto 70% [91, 92]. Abdominal sepsis can be managed by drainage of 
the collection or the focus, resecting the infected foci segment (ranges from 
percutaneous drainage to serial laparotomies and open abdominal wound 
management in severe cases) [93]. 
Health care–associated non-postoperative IAIs, are those arising in patients 
hospitalized for reasons other than abdominal pathology, present with a poor 
prognosis [94]. There is a delay in diagnosis because of low suspicion, poor 
general condition, and altered mental status. Healthcare–associated IAIs are 
associated with pathogens that are multidrug resistant [95] and as a result they 
are treated inadequately as compared to patients with CA-IAIs, resulting in 
failure of treatment and a higher incidence of morbidity and mortality [96]. 
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METHODOLOGY: (MATERIALS AND METHODS) 
 
STUDY CENTRE : INSTITUTE OF GENERAL SURGERY, MMC AND 
RGGGH 
 
SAMPLE SIZE:  30cases of splenectomy/ 30 cases of blunt injury abdomen 
who underwent other laparotomies 
 
DURATION OF STUDY: June 2017 to October 2018 
 
STUDY DESIGN : Prospective Observational Comparative Study 
 
INCLUSION CRITERIA:  
1. All patients undergoing  splenectomy after trauma. 
2. Other blunt trauma patients who underwent laparotomy 
 
Exclusion criteria: Patients undergoing splenectomy for reasons other than 
trauma. 
Assessment of parameters: 
• WBC count 
• Platelet count 
• Injury Severity Score 
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• Presence of postoperative infections such as pneumonia, 
abdominal abscess septicaemia, urinary tract and wound 
infections. 
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DATA ANALYSIS AND 
RESULTS 
  
 
 
STATISTICAL ANALYSIS
GENDER DISTRIBUTION
  
Valid Female
Male
Total
In our study, there were a total of 41 males(68.3%) and 19 females (
59 
 
 
 
Frequency Percent
 19 
 41 
 60 
 
 
 
31.7 
68.3 
100.0 
31.7%) 
 AGE DISTRIBUTION
  
Valid Upto 20 yrs 
21 - 30 yrs 
31 - 40 yrs 
41 - 50 yrs 
51 - 60 yrs 
61 - 70 yrs 
71 - 80 yrs 
Total 
 In our study, the majority study population was between 21
60 
 
 
Frequency Percent 
2 
15 
11 
11 
10 
7 
4 
60 
 
 
 
-30 yrs.
3.3 
25.0 
18.3 
18.3 
16.7 
11.7 
6.7 
100.0 
 
 
 PRESENCE OF INFECTION
  
Valid 
Out of 60 patients, 35 were found to be non infected 
and 25 were diagnosed with postoperative infection. 
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INFECTION 
Frequency Percent 
Yes 25 41.7
No 35 58.3
Total 60 100.0
 
 
 
 
 
 
 
 
42%
58%
Infection
Yes No
 
 
 
 
 
 NATURE OF INFECTION
  
Valid   
AA,SSI
LRI 
LRI,SSI
SSI 
SSI,LRI,UTI
UTI
Total
 
 
0.0
AA,SSI
LRI
LRI,SSI
SSI
SSI,LRI,UTI
UTI
Surgical site infection was the most common infection 
and 15.1% infected 
infection. 
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NATURE 
Frequency Percent 
35 58.3 
 1 1.7 
2 3.3 
 6 10.0 
10 16.7 
 2 3.4 
 4 6.7 
 60 100.0 
  
 
 
 
 
 
 
5.0 10.0 15.0
1.7
3.3
10.0
16.7
3.4
6.7
Nature
individuals had more than one 
 
20.0
   
Valid
In our study, we had a mortality of 5%.
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MORTALITY 
EXPIRED 
Frequency Percent 
 Alive 57 95.0 
Dead 3 5.0 
Total 60 100.0 
 
 
 
 
 
 
 
 
 
 
95%
5%
Mortality
Alive Dead
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COMPARISON OF TOTAL COUNT OF INFECTED VS NON 
INFECTED PERSONS 
Group Statistics 
INFECTION N Mean 
Std. 
Deviation 
Std. 
Error 
Mean 
TC0 Yes 25 15920.00 3449.034 689.807 
No 35 13425.71 4291.122 725.332 
TC1 Yes 25 16088.00 4751.782 950.356 
No 35 13625.71 3960.269 669.408 
TC2 Yes 25 16016.00 3772.895 754.579 
No 35 13222.86 3845.860 650.069 
TC3 Yes 25 16340.00 2889.060 577.812 
No 35 13088.57 3551.369 600.291 
TC4 Yes 25 16036.00 2875.164 575.033 
No 35 13471.43 4714.220 796.849 
TC5 Yes 25 16000.00 2592.457 518.491 
No 35 12088.57 2874.203 485.829 
TC6 Yes 25 15996.00 2899.351 579.870 
No 35 11754.29 3067.989 518.585 
TC7 Yes 25 17084.00 4703.162 940.632 
No 35 11277.14 3596.083 607.849 
TC8 Yes 25 17444.00 4290.695 858.139 
No 35 11857.14 3590.124 606.842 
TC9 Yes 25 17012.00 3434.788 686.958 
No 35 12320.00 3856.454 651.860 
TC10 Yes 25 16864.00 3200.766 640.153 
No 35 11411.43 3565.832 602.736 
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The infected and non-infected patients had similar counts till 
postoperative day 5. After post-operative day 5 the infected group 
had a total count > 15 x 103 / µL and a persistently higher total 
count than the non infected patients. 
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COMPARISON OF MEAN TOTAL COUNT OF SPLENECTOMY VS 
OTHER LAPAROTOMIES 
 
 
 
 
 
Group Statistics 
SURGERY N Mean Std. Deviation Std. Error Mean 
TC0 S 30 15096.67 3319.169 605.995 
O 30 13833.33 4766.502 870.240 
TC1 S 30 15463.33 4044.876 738.490 
O 30 13840.00 4732.762 864.080 
TC2 S 30 15633.33 3382.749 617.603 
O 30 13140.00 4287.882 782.857 
TC3 S 30 15893.33 2240.987 409.146 
O 30 12993.33 4199.830 766.781 
TC4 S 30 16770.00 3029.755 553.155 
O 30 12310.00 4090.978 746.907 
TC5 S 30 14996.67 1375.771 251.180 
O 30 12440.00 4203.250 767.405 
TC6 S 30 15206.67 2282.155 416.663 
O 30 11836.67 3994.693 729.328 
TC7 S 30 15310.00 4922.738 898.765 
O 30 12083.33 4561.313 832.778 
TC8 S 30 16433.33 3995.543 729.483 
O 30 11936.67 4429.485 808.710 
TC9 S 30 16263.33 2864.826 523.043 
O 30 12286.67 4678.029 854.087 
TC10 S 30 15593.33 3454.825 630.762 
O 30 11773.33 4342.011 792.739 
  
Patients who underwent splenectomy had a consistently 
higher total count compared to those who underwent other 
laparotomies 
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COMPARISON OF PLATELET/TOTAL COUNT RATIO IN INFECTED 
VS NON INFECTED PATIENTS 
 
Group Statistics 
INFECTION N Mean 
Std. 
Deviation 
Std. Error 
Mean 
PT0 Yes 25 14.800 7.0648 1.4130 
No 35 19.214 7.7456 1.3092 
PT1 Yes 25 15.756 7.3683 1.4737 
No 35 19.206 7.9405 1.3422 
PT2 Yes 25 15.928 6.5432 1.3086 
No 35 19.360 6.4717 1.0939 
PT3 Yes 25 15.30 6.309 1.262 
No 35 19.93 6.187 1.046 
PT4 Yes 25 14.788 5.6132 1.1226 
No 35 21.017 7.3913 1.2494 
PT5 Yes 25 15.708 5.3141 1.0628 
No 35 25.486 6.0370 1.0204 
PT6 Yes 25 17.156 5.0249 1.0050 
No 35 29.920 6.5257 1.1031 
PT7 Yes 25 18.756 7.9006 1.5801 
No 35 29.717 6.7627 1.1431 
PT8 Yes 25 18.944 8.7158 1.7432 
No 35 30.120 6.0815 1.0280 
PT9 Yes 25 19.068 7.7676 1.5535 
No 35 29.769 6.4454 1.0895 
PT10 Yes 25 20.512 8.6773 1.7355 
No 35 34.034 8.6751 1.4664 
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Patients who were infected were found to have a lower 
platelet count/Total count ratio than non infected patients: the 
difference became statistically significant from the 5th post 
operative day. (P/T Ratio <20) 
 SIGNIFICANCE OF ISS IN INFECTED INDIVIDUALS
 
INFECTION 
  
 
ISS Yes 
 
No 
 
 
 
.00
5.00
10.00
15.00
20.00
25.00
Individuals with higher ISS were found to have a 
significantly higher risk of infection
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N Mean 
Std. 
Deviation 
Std. Error 
   
   
25 23.00 .426 
35 16.00 .374 
 
Yes No
ISS with Infection
 (ISS>21) 
 
Mean 
 
 
.720 
.750 
 
  
SIGNIFICANCE OF PRESENCE OF MO
 
 
 
 
 
 
 
 
 
 
0%
20%
40%
60%
80%
100%
Risk factor with Infection
  
IN Nil 
> 1 RF 
Total 
Presence of more than 1 risk factor increased 
risk of infection by 72%
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RE THAN 1 RISK FACTOR 
FOR INFECTION 
 
 
 
Yes No
Nil > 1 risk factor
INFECTION 
Yes No 
Count 7 32 
% 28.0% 91.4% 
Count 18 3 
% 72.0% 8.6% 
Count 25 35 
% within 
INFECTION 
100.0% 100.0% 
 
 
Total 
39 
65.0% 
21 
35.0% 
60 
100.0% 
72 
 
COMPARISON OF TOTAL COUNTS OF INFECTED VS NON 
INFECTED PATIENTS WHO UNDERWENT SPLENECTOMY  
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Even though both infected and non infected post splenectomy patients had 
higher than normal total counts, from the 5th post op day, the non infected 
patients showed a steady decline in the value reaching high normal values on 
the 10th post operative day, whereas infected patient’s total counts continued 
to rise until treated. (Total count >15x 103 on POD 5 is significant) 
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COMPARISON OF TOTAL COUNTS INFECTED VS NON INFECTED 
PATIENTS WHO UNDERWENT LAPAROTOMIES OTHER THAN 
SPLENECTOMY 
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Though both groups had similar Total counts initially, non 
infected individuals had a steady fall of total count from 
post operative day 2. 
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The total counts of non infected patients who underwent 
splenectomy was persistently higher than those who 
underwent laparotomies. 
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COMPARISON OF TOTAL COUNTS OF INFECTED PATIENTS WHO 
UNDERWENT SPLENECTOMY VS OTHER LAPAROTOMIES  
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Significant difference was not found in total counts of 
infected individuals who underwent splenectomy vs other 
laparotomies. 
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DISCUSSION 
The current study validates the three risk factors: 
• Total count 
• Platelet/ total count ratio 
• Injury severity score 
 for post-splenectomy infections in trauma patients compared to blunt abdomen 
injury patients who underwent laparotomies other than splenectomy. 
 
A similar prospective study was published by Weng J, Brown CV, Rhee P, 
Salim A, Chan L, Demetriades D, Velmahos GC in the journal of trauma in 
May, 2005 but it did not compare splenectomy with other laparotomies.  
Injury severity score was significant in the current study whereas it was not 
found to be significant in the previous study. 
Another similar study published by Toutouzas KG, Velhamos GC, Kaminski A, 
Chan L, Demetriades D in 2002 in Jama surgery journal in August 2002, which 
took into consideration all three factors and found Injury Severity Score >16 to 
be an independent risk factor and presence of more than 1 risk factor predicted a 
50% increased risk of infection . However in the current study, Injury Severity 
Score > 21 was found to be a risk factor and presence of more than 1 risk  factor 
predicts a 72% increased risk of infection. 
The following are the results of the study 
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• Injury severity score >21 is a significant risk factor. 
• Post operative day 5 TC more than 15000 indicates infection. 
• PC/TC ratio < 20 on the 5th post operative day indicates infection. 
• Patients who underwent laparotomies other than splenectomy showed 
elevated Total count and Decreased platelet/total count ratio only if 
infected. 
• Presence of more than 1 risk factor is associated with 72% chance of 
infection. 
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CONCLUSION 
• Post operative day 5 is the earliest time that infected and non infected 
          patients can be distinguished on the basis of total count and PC/TC ratio. 
 
Risk factors for infection 
Total count >15,000 on 5th post operative day 
PC/TC ratio< 20 on 5th post operative day 
ISS > 21 
 
• Presence of more than one risk factor carries 72% increased chance of 
infection and these patients should be monitored with high degree of 
suspicion. 
 
• Presence of increased total count and decreased platelet/total count on 
any post operative day in a patient who has undergone laparotomy other 
than splenectomy should be considered an indicator of infection and 
should be treated promptly. 
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PATIENT CONSENT FORM 
 
STUDY TITLE: “LEUCOCYTOSIS AFTER POST TRAUMATIC SPLENECTOMY- 
A PHYSIOLOGICAL EVENT OR INDICATOR OF SEPSIS “– 
 
Name:        Date: 
 
Age:        IP no :   
 
Sex:   
The details of the above study have been provided to me in writing and explained to 
me in my own language. 
I confirm that I have understood the above study and had the opportunity to ask 
questions. 
I understand that my participation in the study is voluntary and I am free to withdraw 
at any time without giving any reason, without the medical care that will normally be 
provided by the hospital being affected. 
I agree not to restrict the use of any data or results that arise from this study provided 
such a use is only for scientific purposes. 
I have been given an information sheet giving details of the study. 
I hereby consent to participate in this study of “LEUCOCYTOSIS AFTER POST 
TRAUMATIC SPLENECTOMY- A PHYSIOLOGICAL EVENT OR INDICATOR OF 
SEPSIS “– 
 
 
Date:       
        
Place:                 Signature/ thumb impression of the patient     
Patient’s name: 
Signature of the Investigator:  
Name of the investigator: 
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INFORMATION SHEET 
 
• Your blood sample from the first ten post operative days will be accepted. 
 
• We are conducting a study on patients undergoing splenectomy after trauma in Rajiv Gandhi 
Government General Hospital and for that your blood sample will be valuable to us. 
• Patients will be divided into two groups:  
1.Patients undergoing post traumatic splenectomy. 
2. Blunt trauma patients undergoing laparotomy for causes other than splenectomy. 
 
 
• The purpose of this study is to identify the infection and physiologic response of splenectomy 
after trauma with the help of WBC count, Platelet count / WBC count ratio and Injury 
Severity Score. 
 
• We are selecting certain cases and if your blood sample is found eligible, we may be using 
your blood sample to perform certain tests and special studies which in any way do not affect 
your final report or management. 
 
 
• The privacy of the patients in the research will be maintained throughout the study. In the 
event of any publication or presentation resulting from the research, no personally identifiable 
information will be shared. 
 
• Taking part in this study is voluntary. You are free to decide whether to participate in this 
study or to withdraw at any time. Your decision will not result in any loss of benefits to which 
you are otherwise entitled. 
 
• The results of the special study may be intimated to you at the end of the study period or 
during the study if anything is found abnormal which may aid in the management or 
treatment. 
 
 
Signature of the investigator     Signature of the participant 
Date: 
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PATIENT PROFORMA 
Name :    Age :   Sex : 
IP No. : 
DOA:    DOP:    DOD: 
Diagnosis : 
Procedure Done: 
Mode of injury: 
List of injuries: 
Presenting complaints: 
Co-morbid illness: 
Past surgical /Medical history: 
On examination:  
General condition: 
VITALS: 
PR:                             BP:                           RR:                        
CVS: 
RS: 
 
P/A: 
 
PR: 
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Investigation chart: 
 
Post operative day WBC count Platelet count (PC) PC / WBC ratio 
1    
2    
3    
4    
5    
6    
7    
8    
9    
10    
 
 
 
 
 
Injury Severity Score: 
Post Operative Complications: 
Wound infection: 
Respiratory Infection: 
Urinary tract infection: 
Abdominal abscess: 
Septicaemia: 
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Secondary outcomes: 
  Length of ICU stay: 
  Length of hospital stay: 
Mortality: 
Condition on discharge: 
 
 
 
 
S.NO NAME AGE SEX IP NO ISS TC0 P0 PT0 TC1 P1 PT1 TC2 P2 PT2 TC3 P3 PT3 TC4 P4 PT4 TC5 P5 PT5 TC6 P6 PT6 TC7 P7 PT7 TC8 P8 PT8 TC9 P9 PT9 TC10 P10 PT10 SURGERY INFECTION NATURE EXPIRED DURATION OF STAY
1 Thirupathy 45 M 328456 9 10800 196000 18.1 9800 186000 19 8800 171000 19.4 10700 196000 18.3 14200 165000 11.6 14400 351000 24.4 10400 562000 54 16500 600000 36.4 15400 450000 29.2 14600 648000 44.4 10900 650000 59.6 SPLENECTOMY NO NO 12
2 Raman 52 M 412356 25 13000 195000 15 18000 265000 14.7 16800 165000 9.8 17100 196000 11.5 16800 183000 10.9 16800 146000 8.7 20600 406000 19.7 19000 475000 25 16000 452000 28.3 19300 432000 22.4 20400 425000 20.8 SPLENECTOMY YES SSI NO 16
3 Kumar 44 M 213457 22 15400 198000 12.9 14000 120000 8.6 14200 195000 13.7 18000 190000 10.6 16500 198000 12 15600 193000 12.4 15800 213000 13.5 35200 235000 6.7 28800 260000 9 25300 291000 11.5 24100 358000 14.9 SPLENECTOMY YES LRI NO 19
4 Paneerselvam 65 M 984356 24 18000 70000 3.9 6100 60000 9.8 13200 140000 10.6 15200 275000 18.1 16300 27000 16.6 16900 309000 18.3 15400 244000 15.8 15400 635000 41.2 28400 632000 22.3 16500 540000 32.7 19800 525000 26.5 SPLENECTOMY YES SSI NO 15
5 Shanthi 26 F 213478 16 17800 174000 9.8 19400 104000 5.4 17800 346000 19.4 17500 354000 20.2 18500 321000 17.4 15100 456000 30.2 14900 398000 26.7 14800 364000 24.7 14200 485000 34.2 15200 645000 42.4 13200 520000 39.4 SPLENECTOMY NO NO 11
6 Priyan 30 M 334578 21 17000 215000 12.6 24000 224000 9.3 16900 230000 13.6 17000 265000 15.6 16300 198000 12.1 16500 257000 15.6 15800 298000 18.9 19700 356000 18.1 22500 456000 20.3 15200 415000 27.3 15800 546000 34.6 SPLENECTOMY YES LRI,SSI NO 23
7 Shanmugam 46 M 221435 14 7600 144000 18.9 11000 193000 17.5 11600 275000 23.7 11800 129000 10.9 14300 150000 10.5 14700 275000 18.7 14500 324000 22.3 14000 256000 18.3 13200 456000 34.5 14200 465000 32.7 13200 545000 41.3 SPLENECTOMY NO NO 12
8 Punitha 50 F 65432 21 17500 241000 13.8 16500 166000 10.1 17400 195000 11.2 16400 265000 16.2 15000 398000 26.5 14800 412000 27.8 14200 321000 22.6 13600 432000 31.8 12600 654000 51.9 13500 425000 31.5 15400 326000 21.2 SPLENECTOMY NO NO 13
9 Fernandez 25 M 217857 22 13200 168000 12.7 9300 268000 28.8 11200 238000 21.3 17400 355000 20.4 16600 240000 14.5 16900 272000 16.1 20600 365000 17.7 17200 452000 26.3 18900 398000 21.1 20900 412000 19.7 17900 395000 22.1 SPLENECTOMY YES LRI, SSI NO 18
10 Ashok 16 M 214567 22 13000 200000 15.4 19000 265000 13.9 15800 265000 16.8 16000 198000 12.4 17000 176000 10.4 16500 198000 12 16800 265000 15.8 17000 495000 29.1 15400 540000 35.1 19900 451000 22.7 22900 513000 22.4 SPLENECTOMY YES SSI NO 14
11 Santhosh 44 M 224567 27 14100 210000 14.9 16600 122000 7.3 17800 218000 12.2 17000 260000 15.3 16200 220000 13.6 14500 420000 29 13600 422000 31 14000 590000 42.1 14700 425000 28.9 12500 569000 45.5 13000 540000 41.5 SPLENECTOMY NO YES 15
12 Pavithra 28 F 314567 9 19000 187000 9.8 13600 199000 14.6 17500 225000 12.9 16400 245000 14.9 18800 200000 10.6 16000 212000 13.3 16100 320000 19.9 15800 394000 24.9 17000 265000 15.6 15400 360000 23.4 12000 574000 47.8 SPLENECTOMY NO NO 11
13 Madhan 30 M 564789 29 10000 251000 25.1 7400 200000 27 8100 156000 19.3 10800 220000 20.4 11500 165000 14.3 14000 431000 30.8 14300 432000 39.3 15700 600000 38.2 16200 645000 39.8 18500 365000 19.7 19400 465000 24 SPLENECTOMY NO NO 13
14 Shankar 53 M 223145 35 12500 345000 27.6 12600 356000 28.3 14500 325000 22.4 13600 256000 18.8 16100 387000 24 14600 365000 25 13500 456000 33.8 12600 387000 30.7 13000 364000 28 13100 432000 33 13100 582000 44.4 SPLENECTOMY NO NO 11
15 Nandini 45 F 345987 24 15400 248000 16.1 16500 113000 6.8 14500 221000 15.2 16500 298000 18.1 16000 375000 23.4 14100 290000 20.6 13500 421000 31.2 13400 356000 26.6 16400 426000 26 14300 410000 28.7 19700 625000 31.7 SPLENECTOMY NO NO 12
16 Puniyakodi 76 M 908678 25 15900 254000 16 20300 310000 15.3 17000 180000 10.6 16900 198000 11.7 15800 148000 9.4 14400 210000 14.6 14000 613000 43.8 1200 610000 50 14400 510000 35.4 15900 545000 34.3 12300 560000 45.5 SPLENECTOMY NO NO 11
17 Murugan 30 M 45632 21 14600 326000 22.3 20000 320000 16 23500 373000 15.9 18000 265000 14.7 20400 365000 17.9 15400 412000 26.8 21100 500000 23.7 17400 465000 26.7 14900 684000 45.9 18500 640000 34.6 14300 650000 45.5 SPLENECTOMY YES SSI NO 17
18 Madhavan 48 M 2134 24 16400 321000 19.6 17200 236000 13.7 17800 365000 20.5 18900 190000 10.1 17500 165000 9.4 18600 300000 16.1 16000 324000 20.3 16600 394000 23.7 19800 395000 19.9 15600 374000 24 15300 458000 29.9 SPLENECTOMY YES UTI YES 20
19 Ethiraj 51 M 56746 14 19000 110000 5.8 16500 298000 18.1 17400 246000 14.1 16500 297000 18 18400 198000 10.8 14900 378000 25.4 14700 478000 32.5 13500 398000 29.5 14900 487000 32.7 13700 521000 38 17500 465000 26.6 SPLENECTOMY NO NO 12
20 Ram 37 M 234432 11 17400 320000 18.4 17000 364000 21.4 16500 212000 12.8 17400 224000 12.9 28500 398000 14 12800 385000 30.1 14000 421000 30.1 14700 384000 26.1 11000 410000 37.3 17400 698000 40.1 12000 540000 45 SPLENECTOMY NO NO 11
21 Janaki 36 F 56234 11 18600 142000 7.6 18000 116000 6.4 17500 222000 12.7 16300 223000 13.7 15600 198000 12.7 14600 212000 14.5 14200 463000 32.6 12100 469000 38.8 16000 420000 26.3 13900 398000 28.6 14900 390000 26.2 SPLENECTOMY NO NO 11
22 Sengottayan 80 M 23245 17 14900 267000 17.9 15900 345000 21.7 11300 225000 19.9 13600 248000 18.2 16600 300000 18.1 13700 298000 21.8 14300 337000 23.6 15900 265000 16.7 16500 356000 21.6 14200 420000 29.6 12800 567000 44.3 SPLENECTOMY NO NO 15
23 Mohan 39 M 12367 27 24000 162000 6.8 16000 321000 20.1 15600 254000 16.3 16000 300000 18.8 18500 321000 17.4 15300 465000 30.4 14600 356000 24.4 13500 345000 25.6 14000 452000 32.3 19800 354000 17.9 12500 542000 43.4 SPLENECTOMY NO NO 11
24 Annapoorni 64 F 34523 9 14600 210000 14.4. 14300 387000 27.1 15200 175000 11.5 15400 215000 14 14900 320000 21.5 14900 354000 23.8 13600 352000 27.9 13500 328000 24.3 16800 554000 33 19400 374000 19.3 12800 526000 41.1 SPLENECTOMY NO NO 13
25 Thulasi 43 F 87456 25 12500 221000 17.7 17000 132000 7.8 18000 271000 15.1 18600 298000 16 17900 268000 15 14900 365000 24.5 14200 421000 29.6 13300 565000 42.5 13600 453000 33.3 16900 421000 24.9 13100 452000 34.5 SPLENECTOMY NO NO 12
26 Rangaraj 38 M 183758 21 15000 241000 16.1 19300 465000 24.1 20100 245000 12.2 16800 275000 16.4 17200 210000 12.2 15700 219000 13.9 16500 265000 16.1 17400 398000 22.9 16300 420000 25.8 16500 425000 25.8 19300 523000 27.1 SPLENECTOMY YES LRI, SSI NO 27
27 Sujatha 52 F 34565 14 17500 198000 11.2 16500 389000 23.6 16900 385000 22.8 18500 359000 19.4 20900 398000 19 15000 398000 26.5 16900 387000 22.9 16500 488000 29.6 14600 384000 26.3 14800 383000 25.9 14200 412000 29 SPLENECTOMY NO NO 13
28 Chakravarthy 32 M 72234 22 14000 113000 8.1 10200 225000 22.1 12000 210000 17.5 12200 225000 18.4 14500 222000 15.3 12500 300000 24 13000 265000 20.4 13100 332000 25.3 17400 468000 26.9 13900 484000 34.8 17400 450000 25.9 SPLENECTOMY YES UTI NO 19
29 Vadivel 62 M 98345 21 14500 365000 25.2 14900 345000 23.2 13600 254000 18.7 13800 172000 12.5 12500 398000 31.8 12900 201000 15.6 14200 421000 29.6 13200 374000 28.3 13600 341000 25.1 15400 425000 27.6 14000 452000 32.3 SPLENECTOMY NO NO 11
30 Vinod 47 M 34623 16 9700 165000 17 17000 132000 7.8 20500 165000 8 16500 210000 12.7 13800 210000 15.2 12900 574000 44.5 14900 554000 37.2 13500 400000 29.6 16500 398000 24.1 13600 430000 31.6 14600 465000 31.8 SPLENECTOMY NO NO 13
31 Shahida 59 F 12675 11 21000 172000 8.19 22000 174000 7.9 16000 189000 11.8 14000 180000 12.8 12800 180000 14 11700 250000 21.3 9800 235000 23.9 8700 210000 24.1 8100 226000 27.9 7600 232000 30.5 6500 246000 37.8 PRIMARY CLOSURE JEJUNAL PERFORATION NO NO 11
32 Michael 34 M 23876 13 13600 256000 18.8 14300 238000 16.6 11900 221000 18.5 10600 223000 21 9500 243000 25.5 8800 245000 27.8 7600 243000 31.9 7700 245000 31.8 7600 243000 31.9 8000 226000 28.2 7600 234000 30.7 PRIMARY SUTURING LIVER LACERATION NO NO 12
33 Kanthamani 55 F 87456 17 12200 276000 22.6 13400 254000 18.9 12800 236000 18.4 10300 245000 23.7 9800 235000 23.9 9600 234000 24.3 8500 234000 27.5 8700 210000 24.1 7400 228000 30.8 7600 226000 29.7 7200 257000 35.6 NEPHRECTOMY NO NO 16
34 Malarvizhi 65 F 65896 21 22800 194000 8.5 23800 200000 8.4 21900 186000 8.4 18700 195000 10.4 15400 210000 13.6 16500 220000 13.3 18400 212000 11.5 19200 187000 9.7 20000 186000 9.3 22100 216000 9.7 21000 226000 10.7 RESECTION ANASTAMOSISOF JEJUNUM YES SSI NO 22
35 Duraisamy 72 M 43456 11 8900 234000 26.2 8800 245000 27.8 8700 210000 24.1 9500 243000 25.5 9600 234000 24.3 8500 234000 26.2 8100 226000 27.9 7600 232000 30.5 7600 243000 31.9 8700 210000 24.1 7600 232000 30.5 PRIMARY CLOSURE OF BLADDER RENT NO NO 12
36 Vignesh 24 M 34786 19 14000 180000 12.8 12800 236000 18.4 15400 210000 13.6 16500 210000 12.7 12800 180000 14 12800 236000 18.4 15400 210000 13.6 14600 223000 15.2 16200 233000 14.3 16500 398000 24.1 14600 465000 31.8 PRIMARY CLOSURE JEJUNAL PERFORATION YES SSI,LRI NO 22
37 Varadharaj 46 M 98567 16 9800 235000 23.9 9600 234000 24.3 8800 245000 27.8 9500 243000 25.5 8800 245000 27.8 8700 210000 24.1 8800 245000 27.8 7600 235000 30.9 7700 245000 31.8 8700 226000 25.9 8100 226000 27.9 NEPHRECTOMY NO NO 13
38 Elumalai 58 M 108090 16 8700 210000 24.1 9500 243000 25.5 8800 245000 27.8 8100 226000 27.9 7800 236000 30.2 8100 226000 27.9 8500 234000 26.2 8700 210000 24.1 8100 226000 27.9 8400 253000 30.1 8100 213000 26.2 PRIMARY CLOSURE OF DIAPHRAGMATIC RENT NO NO 12
39 Imchan 19 M 11878 21 18700 218000 11.6 17800 224000 12.5 18100 247000 13.6 16700 245000 14.6 16500 210000 12.7 16500 220000 13.3 15400 223000 14.4 16500 220000 13.3 16200 233000 14.3 12800 180000 14 12800 236000 18.4 PRIMARY CLOSURE ILEAL PERFORATION YES SSI NO 18
40 Paulraj 22 M 11675 22 8900 320000 35.9 8700 312000 35.8 9200 305000 33.1 8900 290000 32.5 9800 300000 30.6 10200 280000 27.4 10700 290000 27.1 11000 221000 20 9900 223000 22.5 10100 224000 22.1 10200 280000 27.4 PRIMARY SUTURING LIVER LACERATION YES LRI NO 17
41 Farooq 26 M 23145 19 15400 210000 13.6 16500 220000 13.3 13400 254000 18.9 15400 210000 13.6 12800 236000 18.4 16500 220000 13.3 16200 233000 14.3 18400 212000 11.5 16500 210000 12.7 15400 210000 13.6 16000 232000 14.5 RESECTION ANASTAMOSISOF JEJUNUM YES AA,SSI NO 32
42 Hari 30 M 31465 17 22300 213000 9.5 22100 212000 9.5 21800 223000 10.2 18100 247000 13.6 17800 224000 12.5 16500 210000 12.7 12800 236000 18.4 18100 247000 13.6 16700 245000 14.6 15400 210000 13.6 14600 223000 15.2 RESECTION ANASTAMOSISOF ILEUM YES SSI,LRI NO 36
43 Sowmya 26 F 679009 16 21900 186000 8.4 18900 196000 10.3 17800 221000 12.4 18200 214000 11.7 17600 218000 12.3 14500 222000 15.3 12500 300000 24 14600 223000 15.2 16200 233000 14.3 22100 216000 9.7 16500 220000 13.3 RIGHT HEMICOLECTOMY YES SSI,LRI,UTI YES 35
44 Sridevi 28 F 878908 18 9200 305000 33.1 8900 290000 32.5 8900 320000 35.9 8700 312000 35.8 8900 290000 32.5 10700 290000 27.1 9800 300000 30.6 8500 234000 27.5 9500 243000 25.5 10900 243000 22.2 12300 212000 17.2 PRIMARY CLOSURE OF BLADDER RENT YES UTI NO 22
45 Bujiammal 72 F 568743 36 17800 224000 12.5 18100 247000 13.6 18700 218000 11.6 15400 210000 13.6 14600 223000 15.2 16200 233000 14.3 16500 210000 12.7 18100 247000 13.6 17800 224000 12.5 16500 210000 12.7 16500 220000 13.3 PRIMARY CLOSURE ILEAL PERFORATION YES SSI NO 28
46 Krishnammal 63 F 237986 22 8500 234000 26.2 8700 210000 24.1 8800 245000 27.8 8500 234000 26.2 8100 226000 27.9 7600 232000 30.5 7600 243000 31.9 8500 234000 27.5 8700 210000 24.1 7400 228000 30.8 7600 243000 31.9 NEPHRECTOMY NO NO 12
47 Parthiban 36 M 346727 24 9800 300000 30.6 10200 280000 27.4 9500 243000 25.5 8800 245000 27.8 8100 226000 27.9 9600 234000 24.3 8800 245000 27.8 8100 226000 27.9 7400 228000 30.8 8500 234000 26.2 8700 210000 24.1 PRIMARY SUTURING LIVER LACERATION NO NO 11
48 Kalaivani 36 F 236787 11 8800 245000 27.8 8500 234000 26.2 8100 226000 27.9 9200 305000 33.1 8900 290000 32.5 8100 226000 27.9 8500 234000 26.2 8700 210000 24.1 8500 234000 27.5 8900 290000 32.5 7900 243000 30.7 PRIMARY CLOSURE OF BLADDER RENT NO NO 14
49 Appukutti 69 M 78690 14 14500 232000 16 13800 213000 15.4 13200 223000 16.8 12900 224000 17.3 10900 218000 20 9800 221000 22.5 8800 245000 27.8 8100 226000 27.9 7600 232000 30.5 8500 234000 27.5 8400 253000 30.1 PRIMARY CLOSURE ILEAL PERFORATION NO NO 11
50 Sridhar 23 M 56478 22 17800 221000 12.4 18200 214000 11.7 17600 218000 12.3 14500 222000 15.3 21900 186000 8.4 18900 196000 10.3 17800 224000 12.5 18100 247000 13.6 16500 210000 12.7 18100 247000 13.6 17800 224000 12.5 RESECTION ANASTAMOSISOF ILEUM YES SSI,LRI NO 25
51 Senthil 47 M 349876 18 16500 210000 12.7 18700 218000 11.6 17800 224000 12.5 18100 247000 13.6 16700 245000 14.6 17800 221000 12.4 18200 214000 11.7 17600 218000 12.3 16500 220000 13.3 15400 223000 14.4 16500 220000 13.3 PRIMARY CLOSURE JEJUNAL PERFORATION YES SSI NO 17
52 Raghuvaran 57 F 231456 16 8500 234000 27.5 8700 210000 24.1 7400 228000 30.8 7600 243000 31.9 8700 312000 35.8 9200 305000 33.1 8900 290000 32.5 8800 245000 27.8 8100 226000 27.9 9600 234000 24.3 8400 253000 30.1 PRIMARY CLOSURE OF BLADDER RENT NO NO 11
53 Rahul 23 M 98976 19 13400 254000 18.9 15400 210000 13.6 12800 236000 18.4 16500 220000 13.3 16200 233000 14.3 21800 223000 10.2 18100 247000 13.6 17800 224000 12.5 16500 220000 13.3 15400 223000 14.4 16500 220000 13.3 RESECTION ANASTAMOSISOF ILEUM YES SSI NO 14
54 Vimala 56 F 223654 11 8900 290000 32.5 9800 300000 30.6 10200 280000 27.4 10700 290000 27.1 8500 234000 27.5 8700 210000 24.1 7400 228000 30.8 7600 243000 31.9 8700 312000 35.8 8500 234000 26.2 8700 210000 24.1 PRIMARY SUTURING LIVER LACERATION NO NO 13
55 Prabhakar 66 M 400987 9 8700 312000 35.8 8900 290000 32.5 10700 290000 27.1 8700 210000 24.1 8800 245000 27.8 8500 234000 26.2 8100 226000 27.9 8500 234000 26.2 8700 210000 24.1 7600 232000 30.5 7200 221000 30.6 PRIMARY CLOSURE OF BLADDER RENT NO NO 14
56 Eswaran 58 M 300954 22 16200 228000 14 15800 230000 14.5 12800 221000 17.2 11900 246000 20.6 8700 228000 26.2 8800 245000 27.8 8500 234000 26.2 7400 228000 30.8 8100 226000 27.9 8400 253000 30.1 8100 213000 26.2 PRIMARY CLOSURE ILEAL PERFORATION NO NO 11
57 Nagaraj 37 M 78690 22 18100 247000 13.6 17800 224000 12.5 16500 210000 12.7 17800 224000 12.5 18100 247000 13.6 18700 218000 11.6 15400 210000 13.6 17600 218000 12.3 14500 222000 15.3 17800 224000 12.5 18100 247000 13.6 RESECTION AND ILEOSTOMY YES SSI,UTI,LRI NO 37
58 Riyaz 29 M 321098 17 15400 210000 13.6 14600 223000 15.2 16200 233000 14.3 16500 210000 12.7 13800 213000 15.4 13200 223000 16.8 12900 224000 17.3 10900 218000 20 18200 214000 11.7 17600 218000 12.3 14500 222000 15.3 RESECTION ANASTAMOSISOF ILEUM YES UTI NO 26
59 Sathish 31 M 312876 16 16200 233000 14.3 12800 180000 14 12800 236000 18.4 21900 186000 8.4 18900 196000 10.3 17800 221000 12.4 18200 214000 11.7 18100 247000 13.6 16500 210000 12.7 17600 218000 12.3 16500 220000 13.3 PRIMARY CLOSURE ILEAL PERFORATION YES SSI NO 19
60 Maheshwari 39 F 324679 14 8500 234000 26.2 8100 226000 27.9 7600 232000 30.5 7600 243000 31.9 8500 234000 27.5 8900 290000 32.5 8900 320000 35.9 8700 312000 35.8 8100 226000 27.9 8500 234000 26.2 8700 210000 24.1 PRIMARY SUTURING LIVER LACERATION NO NO 12
